Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 203952

DUOPA (CARBIDOPA; LEVODOPA)
4.63MG/ML;20MG/ML Marketing Status: Prescription

Active Ingredient: CARBIDOPA; LEVODOPA
Proprietary Name: DUOPA
Dosage Form; Route of Administration: SUSPENSION; ENTERAL
Strength: 4.63MG/ML;20MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N203952
Product Number: 001
Approval Date: Jan 9, 2015
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English